AskTheDate.com
Back to calendar

Xeris Biopharma Holdings, Inc. (XERS) Earnings

XERS reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.04
Actual EPS: $-0.18
EPS surprise: -1582.34%
Company overview
Market Cap$1.5B
PriceUSD 8.48
EPS (TTM)-0.10
52-week high10.08
52-week low5.25
SectorHealth Technology
IndustryBiotechnology
Employees435
Buy me a coffee